Back
4D Molecular Therapeutics Stock Predictions
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Sell
47
FDMT
4D Molecular Therapeutics
Last Price:
$4.49
Seasonality Move:
-5.07%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.4D Molecular Therapeutics Stock Forecast
-
Is 4D Molecular Therapeutics Stock Undervalued?The current 4D Molecular Therapeutics [FDMT] share price is $4.79. The Score for FDMT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will 4D Molecular Therapeutics Stock Go Up Next Year?
Data Unavailable
4D Molecular Therapeutics Stock Rating
Data Unavailable
4D Molecular Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
4dmoleculartherapeutics.com
52-Week Data
52-Week High:
28.93
52-Week Low:
2.24
Prediction Charts
Market Cap:
221.9M
Price in USD:
4.79
Volume:
720.3K
Beta:
2.88
Technical Analysis
SMA50:
3.34
SMA100:
3.98
SMA200:
6.88
52-Wk Change:
-78.92%
Stock Predictions
-
Is 4D Molecular Therapeutics stock public?Yes, 4D Molecular Therapeutics is a publicly traded company.
-
What is the 4D Molecular Therapeutics stock quote today?The 4D Molecular Therapeutics stock price is 4.79 USD today.
-
How to buy 4D Molecular Therapeutics stock online?You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-20 | 3.84 | 3.85 | 3.90 | 3.70 |
| May-21 | 3.79 | 3.55 | 3.90 | 3.48 |
| May-22 | 3.51 | 3.60 | 3.66 | 3.46 |
| May-23 | 3.54 | 3.49 | 3.55 | 3.39 |
| May-27 | 3.56 | 3.42 | 3.56 | 3.37 |
| May-28 | 3.44 | 3.47 | 3.50 | 3.40 |
| May-29 | 3.48 | 3.71 | 3.81 | 3.42 |
| May-30 | 3.68 | 3.62 | 3.72 | 3.48 |
| Jun-2 | 3.63 | 3.75 | 3.90 | 3.55 |
| Jun-3 | 3.78 | 3.87 | 3.92 | 3.71 |
| Jun-4 | 3.83 | 3.83 | 4.00 | 3.82 |
| Jun-5 | 3.77 | 3.91 | 3.96 | 3.76 |
| Jun-6 | 3.98 | 4.35 | 4.36 | 3.97 |
| Jun-9 | 4.42 | 4.79 | 4.83 | 4.38 |
4D Molecular Therapeutics Earnings
Data Unavailable
4D Molecular Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, an increase next quarter of $0.26 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.32 per share.
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.